'Unfolding' pathways in neurodegenerative disease

Trends in Neurosciences

Volumn 26, Issue 8, 2003, Pages 407-410

  Forman, Mark S ^a   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; TRANSCRIPTION FACTOR; MEMBRANE PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; DEGENERATIVE DISEASE; ENDOPLASMIC RETICULUM; LEUKODYSTROPHY; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STRESS; ADAPTATION; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; MOUSE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN FOLDING;

ADAPTATION, PHYSIOLOGICAL; ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; ENDOPLASMIC RETICULUM; HUMANS; MEMBRANE PROTEINS; MICE; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PELIZAEUS-MERZBACHER DISEASE; PROTEIN CONFORMATION; PROTEIN FOLDING; STRESS;

EID: 0142090441     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(03)00197-8     Document Type: Short Survey

References (25)

1. Trojanowski J.Q. Tauists, baptists, syners, apostates, and new data. Ann. Neurol. 52:2002;263-265.
2. Bucciantini M., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:2002;507-511.
3. Yankner B.A., et al. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
4. Walsh D.M., et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
5. Xu J., et al. Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8:2002;600-606.
6. Bence N.F., et al. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 292:2001;1552-1555.
7. Kaufman R.J. Orchestrating the unfolded protein response in health and disease. J. Clin. Invest. 110:2002;1389-1398.
8. Niwa M., et al. A role for presenilin-1 in nuclear accumulation of IRE1 fragments and induction of the mammalian unfolded protein response. Cell. 99:1999;691-702.
9. Yang Y., et al. The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Aβ40 and Aβ42 secretion. J. Biol. Chem. 273:1998;25552-25555.
10. Terro F., et al. Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress. J. Neurosci. Res. 69:2002;530-539.
11. Katayama T., et al. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat. Cell Biol. 1:1999;479-485.
12. Sato N., et al. Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression. Nat. Cell Biol. 2:2000;863-870.
13. Nakagawa T., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β Nature. 403:2000;98-103.
14. Sai X., et al. Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid β-protein. J. Biol. Chem. 277:2002;12915-12920.
15. Ryu E.J., et al. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 22:2002;10690-10698.
16. Auluck P.K., et al. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 295:2002;865-868.
17. Imai Y., et al. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275:2000;35661-35664.
18. Imai Y., et al. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell. 105:2001;891-902.
19. Nishitoh H., et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 16:2002;1345-1355.
20. Kouroku Y., et al. Polyglutamine aggregates stimulate ER stress signals and caspase-12 activation. Hum. Mol. Genet. 11:2002;1505-1515.
21. Warrick J.M., et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell. 93:1998;939-949.
22. Gow A., Lazzarini R.A. A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat. Genet. 13:1996;422-428.
23. Gow A., et al. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J. Cell Biol. 140:1998;925-934.
24. Southwood C.M., et al. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron. 36:2002;585-596.
25. Lipsitz D., et al. Apoptotic glial cell death and kinetics in the spinal cord of the myelin-deficient rat. J. Neurosci. Res. 51:1998;497-507.